Trypsin and antitrypsin activities and protein concentration in serial meconium and feces of healthy newborns

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 19, Issue 8, 2006, Pages 477-482

  Lisowska Myjak, Barbara ^a   Pachecka, Jan ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Feces; Fetal development; Meconium; Postnatal development; Proteolytic activity; Trypsin inhibitor activity

Indexed keywords

ANILIDE; BENZOYLARGININE 4 NITROANILIDE; N ALPHA TOSYLARGININE 4 NITROANILIDE; TRYPSIN; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; DRUG ACTIVITY; ECTOPIC PREGNANCY; ENZYME ACTIVITY; FECES ANALYSIS; HUMAN; HUMAN EXPERIMENT; MECONIUM; NEWBORN; NORMAL HUMAN; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; SERIAL ANALYSIS OF GENE EXPRESSION;

ANALYSIS OF VARIANCE; BENZOYLARGININE NITROANILIDE; FECES; FEMALE; FETAL DEVELOPMENT; HUMANS; INFANT, NEWBORN; MALE; MECONIUM; PEPTIDE HYDROLASES; PROSPECTIVE STUDIES; PROTEINS; TRYPSIN; TRYPSIN INHIBITORS;

EID: 33748577192     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050600746720     Document Type: Article

References (19)

1. Gralton KS. The incidence of guiac positive stools in newborns and infants. Pediatric Nursing 1999;25:306-309.
2. Loening-Baucke V, Kimura K. Failure to pass meconium: Diagnosing neonatal intestinal obstruction. Am Family Physician 1999;60:2043-2050.
3. Ostrea EM, Knapp DK, Tannenbaum L, Ostrea AR, Romero A, Salari V, Ager J. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001;138:344-348.
4. Koren G, Nulman I, Chudley AE, Loocke C. Fetal alcohol spectrum disorder. CMAJ 2003;169:1181-1195.
5. Damato EG, Winnen CW. Cytomegalovirus infection: Perinatal implications. J Obstet Gynecol Neonatal Nurs 2002;31: 86-92.
6. Ostrea EM. Understanding drug testing in the neonate and the role of meconium analysis. J Perinat Neonatal Nurs 2001;14:61-85.
7. Lester BM, ElSohly M, Wright LL, Smeriglio VL, Verter J, Bauer CR, Shankaran S, Bada HS, Walls HC, Huestis MA, et al. The maternal lifestyle study: Drug use by meconium toxicology and maternal self-report. Pediatrics 2001;107:309-318.
8. Harries JT. Meconium in health and disease. Br Med Bull 1978;34:75-78.
9. 1-antitrypsin in newborn infants. J Pediatr Gastroenterol Nutr 1997;24: 271-275.
10. 1-antitrypsin in the antenatal period. Br J Clin Pract 1976; 30:168-170.
11. 1-antichymotrypsin in human milk: Origin, concentrations, and stability. Am J Clin Nutr 2002;76:828-833.
12. 1-antitrypsin in amniotic fluid, meconium and cord serum of a homozygote newborn infant. In: Junod AF, Haller R, editors. Lung metabolism. New York: Academic Press Inc; 1975. pp 107-117.
13. Ryley HC, Neale L, Brogan TD, Bray PT. Plasma proteins in meconium from normal infants and from babies with cystic fibrosis. Arch Dis Child 1974;49:901-904.
14. Mullinger M, Palasi M. Tryptic and chymotryptic activity of stools of newborn infants. Pediatrics 1966;38:657-659.
15. Eggermont E. Enzymic activities in meconium from human foetuses and newborns. Biol Neonat 1966;10:266-280.
16. Kori M, Maayan-Metzger A, Shamir R, Sirota L, Dinari G. Faecal elastase 1 levels in premature and full term infants. Arch Dis Child 2003;88:106-109.
17. α-tosyl-L-arginine-p- nitroanilide as substrate in color test and polarographic test of trypsin. Clin Chim Acta 1974;56:23-30.
18. Lowry OH, Rosenbrough NJ, Farr AL, Randall RL. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193:265-275.
19. 1- antitrypsin deficiency. Lancet 1982;1:1441-1443.